Cleared Special

K251024 - TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge (FDA 510(k) Clearance)

Apr 2025
Decision
28d
Days
Class 2
Risk

K251024 is an FDA 510(k) clearance for the TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge. This device is classified as a System, Multipurpose For In Vitro Coagulation Studies (Class II - Special Controls, product code JPA).

Submitted by Haemonetics (Boston, US). The FDA issued a Cleared decision on April 30, 2025, 28 days after receiving the submission on April 2, 2025.

This device falls under the Hematology FDA review panel. Regulated under 21 CFR 864.5425.

Submission Details

510(k) Number K251024 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 02, 2025
Decision Date April 30, 2025
Days to Decision 28 days
Submission Type Special
Review Panel Hematology (HE)
Summary Summary PDF

Device Classification

Product Code JPA - System, Multipurpose For In Vitro Coagulation Studies
Device Class Class II - Special Controls
CFR Regulation 21 CFR 864.5425